InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Prices $50 Million Public Offering 

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.  Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) announced the pricing of an underwritten public offering of 10.3 million common shares at $4.85 per share, generating gross proceeds of approximately $50 million. Cantor and Barclays are serving as joint bookrunning managers for the offering, which is expected to close on […]